Details
Category: Volume 07 Issue 04 April 2019
Hits: 1761

Title: To study the effectiveness of EMLA in the alleviation of pain during Hepatitis B vaccination given at birth

Authors: Dr Hitender Gautam, Dr Deepak Sharma, Dr Rakesh Sharma, Dr Pancham Kumar, Dr Priyanka

 DOI: https://dx.doi.org/10.18535/jmscr/v7i4.05

Abstract

Background and Aims: Effective pain management is a desirable standard of care for newborns and may potentially improve their clinical and neurodevelopmental outcomes. Neonatal pain should be assessed routinely using context-specific, validated and objective pain methods, despite the limitations of currently available tools. Reducing invasive procedures, and using pharmacological, behavioural or environmental measures can be used to manage neonatal pain. Hepatitis-B vaccines are given to all newborns under the universal immunization program. So the present study was planned to know the effectiveness of EMLA in alleviating pain during Hepatitis B vaccination given at Birth.

Methods: 280 neonates were enrolled for the study who are meeting study criteria out of all the newborns who received Hepatitis B vaccine given at birth during study period. They were divided into two groups each with 140 participants. Group 1 had received hepatitis B vaccine after application of EMLA 1hour prior to a vaccine (case group)and group 2 received vaccine after application of placebo (control group). The pain was assessed on NIPS scale in both the groups immediately after immunization, at 30 second and at 60 second after immunization.

Results: NIPS scores at all the intervals were significantly lower when the vaccine was given after EMLA (Group 1) compare to group 2 who was immunized after placebo (P value of<0.0001)

Conclusion: Pain perceived by the newborn after EMLA application during hepatitis B vaccine was less as compared to the placebo group.

Keywords: neonatal infant pain scale score (NIPS), Hepatitis B vaccine, intramuscular, EMLA (eutectic mixture of lidocaine and prilocaine).

References

  1. Paediatrics & Child Health Division, The Royal Australasian College of Physicians. Guideline statement: management of procedure-related pain in children and adolescents. J Paediatr Child Health 2006; 42(suppl. 1): S1–S29
  2. Taddio A, Manley J, Potash L, et al. Routine immunization practices: use of topical anesthetics and oral analgesics. Pediatrics 2007; 120: e637–e643.
  3. Institute of Medicine (homepage on the internet). Childhood immunization schedule and safety: stakeholder concerns , scientific evidence, and future studies. Updated January 16,2013 . available from :http://www.iom.edu/reports/2013/The childhood –immunization-schedule-safety.aspx. Access July 14, 2014.
  4. World Health Organization. World health assembly endorses new plan to increase global access to vaccines [press release]. Geneva: World Health Organization; [May 25,2012].Availablefrom: http://www.who. int/immunization/newsroom/press/wha_endorses_gvap/en. Accessed July 14, 2017.
  5. Mitchell A, Boss BJ. Adverse effects of pain on the nervous systems of newborns and young children: a review of the literature. J Neurosci Nurs. 2002 Oct; 34(5) :228-36.
  6. Brady K, Avner JR, Khine H. Perception and attitude of providers towards pain and anxiety associated with pediatric vaccine injection. Chn pediatr; 2011;50(2):140-143.
  7. Luthy KE, Beckstrand RL, Asay W, Hewett C. Vaccination parent experience vaccine anxiety too. J AM Assoc Nurse Pract. 2013;25(12):667-673.
  8. Gourrier E, Karoubi P, EI Hanache A, et al. Use of EMLA cream in premature and full term newborn infants, JAMA. 1993;270:850-853.
  9. Halperin DL, Koren G, Attias. D, Pelegrini E, Greenberg ML, Wyss M. Topical skin anaesthesia for venous, subcutaneous drug resorvior and lumber puncture in children, Paediatrics.1998; 101:1-9.
  10. Pereira AL, GuinsburgR, de Almeda MF, Monterio AC, dos Santos AM, Kopelman, BI. Validity of behavioural and physiological parameter for acute pain assessment of term newborn infants. Sao Paula Med J.1999;117;72-80.
  11. Brazelton TB, Nugent JK. The Neurobehavioural Assessment Scale. 3 rd ed. London: Mac Keith Press; 1995.
  12. EMLA EMLA FDA available on (https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/19941s11lbl.pdf) last accessed 18.03.2019
  1. Lawrence J, Alcock D, McGrath P, KayJ, MacMurray SB, andDulberg C. The development of a tool to assess neonatal pain. Neonatal Netw. 1993 Sept; 12(6): 59–66.
  2. Uhari M. A eutectic mixture of lidocaine and prilocaine for alleviating vaccination pain in infants. Pediatric 1993; 719- 721.
  3. Dilli D, Göker Küçük I, Dallar Y. Interventions to reduce pain during vaccination in infancy. J Pediatr. 2009; 154:385–390.

Corresponding Author

Dr Priyanka

Resident, Department of Community Medicine, IGMC, Shimla, Himachal Pradesh, India